Hodgkin lymphoma trials in Hungary

3 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 13 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma

  Where

  Budapest IX, Budapest XII, Debrecen, Eger, Győr, Szeged, Székesfehérvár, Szekszárd

  Age

  18 years and over

  People

  386 worldwide

  Run by

  Grifols Therapeutics LLC

  See details and how to joinNCT05645107 · EU 2022-502193-16-00
• Phase 1/2Taking people
  A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity of Glofitamab in Monotherapy and in Combination with Chemoimmunotherapy in Pediatric and Young Adult Participants with Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphoma

  Where

  Budapest

  Age

  Up to 17 years

  People

  37 worldwide

  Run by

  F. Hoffmann-La Roche AG

  See details and how to join2023-504264-41-00
• Phase 3Taking people
  A trial to learn how effective and safe odronextamab is compared to standard of care for adult participants with previously treated aggressive B-cell Non-Hodgkin Lymphoma.

  Where

  Budapest VIII, Debrecen, Pécs

  Age

  18 years and over

  People

  132 worldwide

  Run by

  Regeneron Pharmaceuticals Inc.

  See details and how to joinNCT06230224 · EU 2022-502783-21-00